Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.

@article{Rauch2003BoneMS,
  title={Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.},
  author={Frank Rauch and Horacio Plotkin and Leonid Zeitlin and Francis H Glorieux},
  journal={Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research},
  year={2003},
  volume={18 4},
  pages={610-4}
}
Cyclical intravenous therapy with pamidronate improves the clinical course in children and adolescents with osteogenesis imperfecta (OI). In this study, we evaluated the effect of this therapy on lumbar spine bone mass (bone mineral content [BMC]), size (bone volume [BV]), and density (volumetric bone mineral density [vBMD]). Results from 56 patients (age, 0.2-15.9 years; 25 girls) on long-term pamidronate treatment were compared with those of 167 patients who had not received pamidronate… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 66 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

resorption rates in children monitored by the urinary assay of collagen type I cross - linked peptides

  • F Rauch, R Travers, H Plotkin, FH Glorieux
  • Bone
  • 2002

Similar Papers

Loading similar papers…